Toggle Main Menu Toggle Search

Open Access padlockePrints

Synergistic effects of systemic trefoil factor family 1 (TFF1) peptide and epidermal growth factor in a rat model of colitis

Lookup NU author(s): Dr Meiyi Pu, Professor Bruce Westley, Dr Felicity May


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Novel therapies for the treatment of colitis are required. We therefore examined the potential value of the trefoil factor family 1 (TFF1) peptide and epidermal growth factor (EGF) alone and in combination. Effects of TFF1-Cys 58±EGF on an in vitro HT29 cell wounding model of restitution showed synergistic activity when used in combination. In addition, animals had colitis induced by adding 4% dextran sulphate sodium (DSS) to the drinking water for 7 days and they also received twice daily subcutaneous injections of test peptides. Treatment with TFF1-Cys58 alone (100 μg/kg) reduced histological colitis score by 22%, but the TFF1-Ser58 variant was ineffective. In a second study, TFF1-Cys58 reduced histological colitis score by 15%, EGF (600 μg/kg) by 26%, and an additive response (42% reduction) was demonstrated when used together (P<0.01 versus either peptide given alone). Similar results were found using tissue myeloperoxidase (MPO) activity as a marker of inflammation. Where clinical risk/benefit seems justified, these initial studies suggest that combination therapy of systemic EGF and TFF peptides may prove useful for treatment of colitis in patients with disease extending beyond the reach of topical (enema) therapy. © 2004 Elsevier Inc. All rights reserved.

Publication metadata

Author(s): FitzGerald A, Pu M, Marchbank T, Westley BR, May FEB, Boyle J, Yadollahi-Farsani M, Ghosh S, Playford R

Publication type: Article

Publication status: Published

Journal: Peptides

Year: 2004

Volume: 25

Issue: 5

Pages: 793-801

Print publication date: 01/05/2004

ISSN (print): 0196-9781

ISSN (electronic): 1873-5169


DOI: 10.1016/j.peptides.2003.12.022

PubMed id: 15177874


Altmetrics provided by Altmetric